Editas Medicine, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Editas Medicine, Inc. reported Cash And Cash Equivalents At Carrying Value of $146.65 million for the year ending 2025.

  • Editas Medicine, Inc. showed an increase of +11.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Editas Medicine, Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
  • XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 13 years of available data (2013 to 2025), Editas Medicine, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 7,188.5%.
  • Historical annual values: Fiscal year 2025: $146.65 million | Fiscal year 2024: $131.54 million | Fiscal year 2023: $123.65 million | Fiscal year 2022: $141.52 million | Fiscal year 2021: $203.52 million | Fiscal year 2020: $139.68 million | Fiscal year 2019: $238.18 million | Fiscal year 2018: $134.78 million | Fiscal year 2017: $146.63 million | Fiscal year 2016: $185.32 million | Fiscal year 2015: $143.18 million | Fiscal year 2014: $10.62 million | Fiscal year 2013: $2.01 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: